Rituximab – a double-edged sword: can one treatment for thrombocytopenia also induce it?

Ron Ram Institute of Hematology, Rabin Medical Center, Beilinson Hospital, Petah-Tiqva, Israel; Sackler School of Medicine, Tel Aviv University, Ramat Aviv, Israel

Pia Raanani Institute of Hematology, Rabin Medical Center, Beilinson Hospital, Petah-Tiqva, Israel; Sackler School of Medicine, Tel Aviv University, Ramat Aviv, IsraelCorrespondence[email protected]

"Rituximab – a double-edged sword: can one treatment for thrombocytopenia also induce it?." Leukemia & Lymphoma, 49(11), pp. 2035–2036

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Rituximab – a double-edged sword: can one treatment for thrombocytopenia also induce it?

Information for

Open access

Opportunities

Help and information

Rituximab – a double-edged sword: can one treatment for thrombocytopenia also induce it?

Reprints and Corporate Permissions

Academic Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date

Your download is now in progress and you may close this window

Login or register to access this feature